{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["207(6)"],"submitter":["Salvino MA"],"funding":["Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, USA"],"journal":["British journal of haematology"],"pagination":["2583-2587"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12710109"],"repository":["biostudies-literature"],"pubmed_title":["A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma."],"pmcid":["PMC12710109"],"pubmed_authors":["Kobayashi R","Zecca M","Salvino MA","Locatelli F","Luisi FAV","Sidi Y","Zhou X","Bai X","Pianovski MA","Fagioli F","Koga Y","Filho VO","Lima LBA","Campana F","Bush R","Epelman S","Favre C"],"additional_accession":[]},"is_claimable":false,"name":"A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-07-04T03:21:30.992Z","creation":"2026-07-04T03:12:19.825Z"},"accession":"S-EPMC12710109","cross_references":{"pubmed":["41084939"],"doi":["10.1111/bjh.70207"]}}